Rationale and Design of VOYAGER: Long-term Outcomes of Faricimab and Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema in Clinical Practice

Purpose: To describe the rationale and design of the VOYAGER (NCT05476926) study, which aims to investigate the safety and effectiveness of faricimab and the Port Delivery System with ranibizumab (PDS) for neovascular age-related macular degeneration (nAMD) or diabetic macular edema (DME) in clinica...

Full description

Bibliographic Details

Published in:	Ophthalmology Science
Main Authors:	Robyn Guymer, MBBS, PhD, Clare Bailey, MD, FRCP, Voraporn Chaikitmongkol, MD, Usha Chakravarthy, FRCOphth, PhD, Varun Chaudhary, MD, FRCS(C), Robert P. Finger, MD, PhD, Roberto Gallego-Pinazo, MD, PhD, Adrian Koh Hock Chuan, MBBS, MMed (Ophth), Susumu Ishida, MD, PhD, Monica Lövestam-Adrian, MD, PhD, Mariacristina Parravano, MD, Jose D. Luna Pinto, MD, Steffen Schmitz-Valckenberg, MD, Veeral Sheth, MD, MBA, Eric H. Souied, MD, PhD, Gloria C. Chi, PhD, MPH, Frank Gilberg, PhD, Carl Glittenberg, MD, Stefan Scheidl, MSc, PhD, Monica Bengus, MD
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Subjects:	Diabetic macular edema Faricimab Neovascular age-related macular degeneration Port Delivery System with ranibizumab Real-world study
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666914523001744